Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Kelly Papesh

Nurse Practitioner, Family Las Vegas, NV Nurse Practitioner

NPI 1386181782 CMS profile 10785886

888 W Bonneville Ave, Las Vegas, NV 89106

Open in the dashboard

General payments

$28,248

183 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$15,500 paid to institutions, not to them · program year 2025

Through program year 2025, Kelly Papesh of Las Vegas, NV is reported in the CMS Open Payments database as having received $28,248 across 183 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $15,500 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Family profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,176 33
2024 General $3,231 41
2023 General $3,219 15
2022 General $6,175 62
2021 General $10,446 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kelly Papesh
  • Nurse Practitioner, Family median
  • Middle half of Nurse Practitioner, Family
  • National median

In program year 2025, general payments to Kelly Papesh were reported at $5,176. Among 107,232 Nurse Practitioner, Family profiles paid that year, the median was $168 and the middle half received between $53 and $521.

Show as a table
Year Kelly Papesh Nurse Practitioner, Family median Middle half National median
2019 $0 $39 $18–$91 $163
2020 $0 $32 $17–$76 $114
2021 $10,446 $124 $35–$379 $132
2022 $6,175 $141 $44–$430 $149
2023 $3,219 $154 $49–$476 $160
2024 $3,231 $165 $51–$504 $164
2025 $5,176 $168 $53–$521 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Amneal Pharmaceuticals LLC $10,272 33 payments
  2. Acorda Therapeutics, Inc $5,294 23 payments
  3. AbbVie, Inc. $4,581 37 payments
  4. Mitsubishi Tanabe Pharma America, Inc. $3,797 7 payments
  5. Merz Pharmaceuticals, LLC $1,452 24 payments
  6. Abbott Laboratories $1,028 10 payments
  7. ACADIA Pharmaceuticals Inc $428 9 payments
  8. Boston Scientific Corporation $326 3 payments
  9. US WorldMeds, LLC $281 2 payments
  10. Neurocrine Biosciences, Inc. $191 6 payments
  11. Other $600 29 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,785 15 payments
  2. Food and Beverage $7,718 144 payments
  3. Honoraria $5,874 11 payments
  4. Consulting Fee $5,085 5 payments
  5. Travel and Lodging $787 8 payments
Products named General payments · program years 2021–2025
  1. RYTARY $7,993 19 payments
  2. DUOPA $3,948 23 payments
  3. INBRIJA Parkinson's Disease $3,107 16 payments
  4. INBRIJA Parkinsons Disease $2,186 7 payments
  5. CREXONT $930 13 payments
  6. Xeomin musculoskeletal $668 11 payments
  7. VYALEV $536 6 payments
  8. INFINITY Structural Heart $533 5 payments
  9. INFINITY Neuromodulation $464 3 payments
  10. Xeomin musculoskeletal $461 7 payments
  11. Other $2,190 67 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

183 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Family in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record